![]() |
| Stocks Up |
Ranbaxy Laboratories after market hours on Tuesday, 29 October 2013, reported consolidated net loss of Rs 454.16 crore in Q3 September 2013, compared with net profit of Rs 754.17 Crore in Q3 September 2012. Total income increased 1.92% to Rs 2827.73 crore in Q3 September 2013 over Q3 September 2012. Ranbaxy, which announced results after market hours, has changed its financial year to April-March from January-December earlier; hence, the current financial year will be for a period of 15 months from January 2013 to March 2014.
Money Capital Height Research Pvt Ltd helps you to understand the stock market. With extensive research of past cycles, you can start to see the pattern, what it is based on how to use it to forecast the stock prices. Feel free to visit www.capitalheight.com/stock-tips.php or call at +91 - 731 - 6615050

No comments:
Post a Comment